As POT1 and MED12 mutations have been previously associated with poor prognosis in CLL patients [24, 25], we tested the trend of median survival of the 4 POT1-mutated UR-CLL cases. The gene discussed is POT1; the disease is B-cell chronic lymphocytic leukemia.